AbbVie vs Tesla: Founders, CEOs and History
AbbVie was founded in 2013 by Abbott Laboratories (spin-off origin) and is led by Robert A. Michael. Tesla was founded in 2003 by Martin Eberhard, Marc Tarpenning, Elon Musk and is led by Elon Musk.
Company facts
Founders
AbbVie
Abbott Laboratories (spin-off origin)
Abbott Laboratories was AbbVie's corporate predecessor. AbbVie's official launch materials describe the company as formed in 2013 following separation from Abbott. Richard A.
Tesla
Martin Eberhard
Martin Eberhard is an American electrical engineer who co-founded Tesla Motors and was its first CEO. He had earlier co-founded NuvoMedia, the company that made the Rocket eBook.
Marc Tarpenning
Marc Tarpenning co-founded Tesla Motors in 2003 and served in early finance, engineering and operating roles, including CFO and vice president of engineering.
Elon Musk
Elon Musk's role in Tesla's founding story is best understood as financier, chairman, product force and later crisis CEO.
JB Straubel
JB Straubel became Tesla's founding CTO and one of the most important technical architects in the company's history.
Ian Wright
Ian Wright is listed among Tesla's early founding figures because he contributed to the company's initial vehicle thinking and engineering direction.
CEOs and their tenures
AbbVie
- Richard A. Gonzalez2013–2024
Founding Chairman and Chief Executive Officer
Served as AbbVie's chief executive officer from its formation in 2013 through June 2024 and as executive chairman through June 2025.
Source - Robert A. Michael2024–present
Chairman and Chief Executive Officer
Became chief executive officer on July 1, 2024 and chairman on July 1, 2025. He previously led finance, commercial operations, and corporate strategy roles at AbbVie.
Source
Tesla
- Martin Eberhard2003–2007
Chief Executive Officer
Served as founding CEO from 2003 to August 2007, establishing the core technical thesis of high-performance electric vehicles and directing early engineering on the EP1 and EP2 Roadster prototypes before development delays and cost overruns prompted a board re…
Source - Ze'ev Drori2007–2008
Chief Executive Officer
Served as CEO from November 2007 to October 2008 during Tesla's initial manufacturing transition, bringing the Roadster from troubled prototypes into customer deliveries and establishing production discipline before handing leadership to Elon Musk.
Source - Elon Reeve Musk2008–present
CEO
Led Tesla's transformation from a niche electric roadster project into the world's leading EV manufacturer, scaling global Gigafactories, Supercharger infrastructure, and autonomous driving architectures.
Source
Timeline: AbbVie and Tesla side by side
2003Tesla
Tesla Motors Founded
Tesla Motors was founded in 2003 by Martin Eberhard and Marc Tarpenning to prove that lithium-ion batteries could power a desirable electric car.
2004Tesla
Elon Musk Leads Series A
Elon Musk led Tesla's Series A financing in 2004 and became chairman. The investment gave Tesla enough capital and public credibility to continue Roadster development.
2008Tesla
Roadster Launch
The Roadster launched in 2008 as a highway-capable electric sports car with more than 200 miles of range. It mattered because it proved an EV could be fast, premium and emotionally desirable.
2008Tesla
Elon Musk Becomes CEO
Musk became CEO in 2008 during a severe financing and production crisis. He restructured operations, secured emergency funding and pushed the company toward a clearer product sequence.
2010Tesla
Tesla IPO
Tesla went public in 2010, raising capital while still far from stable profitability. The IPO mattered because it gave Tesla access to public-market funding for product development and manufacturing.
2012Tesla
Model S Launch
The Model S launched in 2012 and moved Tesla beyond the Roadster niche. It mattered because it combined range, software, performance and premium design in a vehicle Tesla controlled more fully.
2013AbbVie
AbbVie Launches as an Independent Company
AbbVie launched after Abbott Laboratories separated its research-based pharmaceutical business and began NYSE trading under ABBV.
2014Tesla
Gigafactory Strategy Announced
Tesla announced the Gigafactory strategy in 2014 with Panasonic as a key partner. The move mattered because batteries were the limiting input for EV scale, cost and range.
2015AbbVie
Pharmacyclics Acquisition Completed
AbbVie completed its acquisition of Pharmacyclics, adding Imbruvica and expanding its hematologic oncology business.
2016Tesla
SolarCity Acquired
Tesla's 2016 SolarCity acquisition is company-specific because it changed the portfolio rather than simply adding scale. The reported value was $2.6B.
2017Tesla
Model 3 Production Crisis
The Model 3 ramp in 2017 exposed severe bottlenecks caused partly by excessive automation. The crisis mattered because Tesla's mass-market strategy depended on producing a lower-priced vehicle at high volume.
2019AbbVie
Skyrizi Receives Initial U.S. Approval
The FDA approved Skyrizi for adults with moderate to severe plaque psoriasis in April 2019.
2019AbbVie
Rinvoq Receives Initial U.S. Approval
The FDA approved Rinvoq for adults with moderate to severe rheumatoid arthritis in August 2019.
2020AbbVie
Allergan Acquisition Completed
AbbVie completed the Allergan acquisition, adding neuroscience, eye care, and Allergan Aesthetics products including Botox and Juvederm.
2020Tesla
S&P 500 Inclusion
Tesla joined the S&P 500 in 2020 after proving sustained profitability. The milestone mattered because it brought index-fund ownership, wider institutional attention and validation that Tesla was no longer a speculative startup.
2023AbbVie
U.S. Humira Biosimilar Competition Begins
Humira began facing U.S. biosimilar competition, and AbbVie reported a subsequent decline in Humira revenue.
2023Tesla
Global Price Cuts
Tesla cut prices across major markets in 2023 to defend demand and pressure competitors. The move mattered because it showed Tesla could use its direct-sales model to adjust faster than dealer-based rivals.
2024AbbVie
ImmunoGen Acquisition Completed
AbbVie completed its acquisition of ImmunoGen, adding Elahere and antibody-drug conjugate programs.
2024AbbVie
Robert A. Michael Becomes CEO
Robert A. Michael succeeded Richard A. Gonzalez as chief executive officer effective July 1, 2024.
2024AbbVie
Cerevel Therapeutics Acquisition Completed
AbbVie completed its acquisition of Cerevel Therapeutics, adding clinical-stage neuroscience programs.
2025AbbVie
Robert A. Michael Becomes Chairman
Robert A. Michael added the chairman role effective July 1, 2025, when Richard A. Gonzalez retired from the board.
2025AbbVie
FY2025 Revenue Reaches $61.160 Billion
AbbVie reported FY2025 net revenue of $61.160 billion and net income of $4.226 billion.
2025Tesla
$94.8B Revenue and Delivery Decline
In FY2025, Tesla reported $94.8B in revenue and delivered 1,636,129 vehicles. The milestone mattered because revenue and deliveries both showed the company had entered a more mature, contested phase.
2026AbbVie
Q1 2026 Revenue Reaches $15.002 Billion
AbbVie reported first-quarter 2026 net revenue of $15.002 billion, up 12.4 percent on a reported basis.
Acquisitions
AbbVie
- ImmunoGen, Inc.2024$10.1B
- Cerevel Therapeutics2024$8.7B
- Allergan plc2020$63B
- Pharmacyclics, Inc.2015$21B
Tesla
- Maxwell Technologies2019$218M
- DeepScale2019Undisclosed
- Hibar Systems2019Undisclosed
- Perbix Machine Company2017$10.5M
- SolarCity2016$2.6B
- Grohmann Engineering2016$135M
Questions about AbbVie vs Tesla
Who is the CEO of AbbVie Inc. and Tesla, Inc.?
AbbVie Inc. is led by Robert A. Michael and Tesla, Inc. is led by Elon Musk. Both serve as the top executive responsible for the company's strategy, operations, and financial performance.
When was AbbVie Inc. founded vs Tesla, Inc.?
Tesla, Inc. was founded in 2003 — 10 years before AbbVie Inc., which was founded in 2013. Tesla, Inc.'s longer operating history gives it a deeper track record but also potentially more institutional inertia compared to the younger AbbVie Inc..
How many employees does AbbVie Inc. have compared to Tesla, Inc.?
AbbVie Inc. employs approximately 57,000 people, while Tesla, Inc. employs approximately 134,785. Tesla, Inc. has the larger workforce at 134,785 employees, compared to AbbVie Inc.'s 57,000. A higher headcount does not necessarily imply greater efficiency — it often reflects differences in business model (e.g., manufacturing vs. software).
Where are AbbVie Inc. and Tesla, Inc. headquartered?
Both AbbVie Inc. and Tesla, Inc. are headquartered in United States, meaning they operate under the same primary regulatory and tax environment.
Who founded AbbVie Inc. and Tesla, Inc.?
AbbVie Inc. was founded by Abbott Laboratories (spin-off origin). Tesla, Inc. was founded by Martin Eberhard, Marc Tarpenning, Elon Musk, JB Straubel, Ian Wright.
Which company has a longer operating history — AbbVie Inc. or Tesla, Inc.?
Tesla, Inc. has been operating for approximately 23 years, making it the more established of the two companies. AbbVie Inc. has been in operation for around 13 years. A longer operating history often signals greater institutional resilience and brand recognition, though it can also mean slower adaptation to new market conditions.
Figures come from each company's filings and the sources linked beside them. Amounts reported in another currency are shown in US dollars at an approximate rate and marked with ~. Back to the AbbVie vs Tesla overview